Public Health Archives - Page 33 of 34

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

Palleon Pharmaceuticals Doses First Patient in Phase 2 Trial of E-602 for Autoimmune Kidney Disease

August 7, 2025

2Life Communities Names Denise McQuaide Chief of Middle Market Innovation to Lead New Senior Living Model

August 7, 2025

First FDA-Approved Treatment for MacTel Administered Following Commercial Launch

August 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Washington Trust Wins Exemplary Worksite Health Award for Ninth Consecutive Year

Nearly Half of Americans Delay Healthcare Due to Cost and Insurance Barriers, Madaket Health Survey Finds

Majority of Americans Support Water Fluoridation, New Survey Finds

Stronger Gun Laws Linked to Fewer Firearm Suicides, While Socioeconomic Factors Drive Homicides, Northwell Health Study Finds

AHF Launches National Ad Campaigns Targeting HIV Stigma and Promoting STD Testing

Most Read

KnoWEwell Names Functional Medicine Leader Dr. Patrick Hanaway as Chief Medical Officer

Survey Finds Pediatricians Prefer Genexa’s Ingredient Profiles Over Children’s Tylenol® Products

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

Palleon Pharmaceuticals Doses First Patient in Phase 2 Trial of E-602 for Autoimmune Kidney Disease

2Life Communities Names Denise McQuaide Chief of Middle Market Innovation to Lead New Senior Living Model

First FDA-Approved Treatment for MacTel Administered Following Commercial Launch

POPULAR CATEGORY

ABOUT US

FOLLOW US